| __timestamp | Apellis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 241751000 |
| Thursday, January 1, 2015 | 13730311 | 322292000 |
| Friday, January 1, 2016 | 22978599 | 344320000 |
| Sunday, January 1, 2017 | 40303878 | 374644000 |
| Monday, January 1, 2018 | 105285576 | 414604000 |
| Tuesday, January 1, 2019 | 220968770 | 466000000 |
| Wednesday, January 1, 2020 | 299921000 | 535000000 |
| Friday, January 1, 2021 | 420869000 | 643000000 |
| Saturday, January 1, 2022 | 387236000 | 833000000 |
| Sunday, January 1, 2023 | 354387000 | 899625000 |
| Monday, January 1, 2024 | 901530000 |
Data in motion
In the ever-evolving world of pharmaceuticals, innovation is the key to staying ahead. Ionis Pharmaceuticals, Inc. and Apellis Pharmaceuticals, Inc. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Ionis consistently outspent Apellis, with R&D expenses peaking at nearly 900% higher than their 2014 levels by 2023. Apellis, while trailing, showed a remarkable growth trajectory, increasing their R&D spending by over 4000% during the same period. This commitment to innovation is crucial as both companies strive to develop groundbreaking treatments. The data highlights a clear trend: Ionis is leading the charge, but Apellis is rapidly closing the gap. As the pharmaceutical landscape continues to shift, these investments will likely play a pivotal role in shaping the future of healthcare.
Analyzing R&D Budgets: Merck & Co., Inc. vs Apellis Pharmaceuticals, Inc.
United Therapeutics Corporation or Ionis Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Apellis Pharmaceuticals, Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Madrigal Pharmaceuticals, Inc. and Apellis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Xencor, Inc.